1-781-759-7018
Technology
Transversal Therapeutics aims to revolutionize point of care and over the counter diagnostic solutions.
A Highly Sensitive, Versatile Sensor
Revolutionizing Diagnostics

Our innovative electrochemical sensors are built on years of rigorous research and development, aimed at delivering highly sensitive, rapid, and adaptable diagnostic solutions. With extensive experience in various sensor modalities, we are uniquely positioned to incorporate the strongest design elements from each modality, allowing us to develop sensors that are not only specialized for high-impact applications but also retain the flexibility and scalability required in today’s evolving healthcare landscape.


At the core of our platform is a proprietary enzymatic drop-deposition process that enhances the functionality and durability of our sensors. This process significantly improves sensor stability, extends shelf life, and enables efficient, scalable manufacturing—all crucial factors for broad and sustained deployment in medical settings. Unlike many traditional sensors that may suffer from short shelf lives or complicated manufacturing requirements, our patented approach ensures that the sensors remain reliable, cost-effective, and accessible to healthcare providers and patients alike.



The Adaptability of a Platform

Our platform’s unique architecture enables considerable overlap in sensor design, shortening development timelines and accelerating time-to-market for new applications. This allows us to address emerging diagnostic needs quickly and at a fraction of the cost typically associated with new diagnostic tools. Initially, we develop single-analyte sensors designed to detect specific biomarkers, compatible with a variety of relevant testing media such as saliva, and blood. By leveraging these non-invasive or minimally invasive and accessible sample types, we make diagnostics more convenient for patients while maintaining the accuracy and reliability demanded by healthcare providers.


One of the core advantages of our platform is its adaptability and ability to be panelized. These panels can be customized to simultaneously detect several biomarkers of a common class of diseases or analytes, providing comprehensive diagnostics in a single test in a myriad of medical fields. 


Toxicology

Our platform’s versatility is particularly impactful in the field of toxicology, where rapid, accurate quantification of small molecule drugs-of-abuse (DoA) or therapies is essential for improving patient outcomes, especially in cases involving Opioid use Disorder and other substance dependencies. Synthetic opioids accounted for ~80% of overdose deaths in the past year, and Transversal aims to attack this devastating crisis from multiple angles. We are currently seeking non-dilutive funding for and developing a suite of toxicology sensors that will give healthcare providers real-time, on-the-spot data during a single visit. This rapid feedback loop is invaluable in managing patient care, allowing for timely interventions that can prevent overdoses, enabling the development of rapid detox protocols, and guiding dosage adjustments and provider concerns with medication assisted therapies to drastically improve treatment efficacy. Our sensors can measure key toxicological markers with precision, setting a new standard in point-of-care toxicology diagnostics and paving the way for precision medicine to combat the opioid crisis.


A Technology of the Future

Looking ahead, we plan to expand our platform into a variety of diagnostic fields, including infectious diseases, metabolic and cardiovascular health, and oncology. Each of these fields presents unique challenges and opportunities for innovation. By developing a platform that is both versatile and rooted in proven electrochemical technology, Transversal Therapeutics is well-positioned to set a new standard in diagnostics. 


Point of Care

Healthcare providers will enjoy the convenience of single sample comprehensive panels that can be performed in a matter of minutes for the price of single target point of care tests from competing technologies. A platform as such will alleviate patient anxiety, enable more effective treatment planning and early intervention, and address challenges such as antibiotic-resistant bacteria.

Over the Counter

Imagine identifying the cause of your sore throat, cough, or fever with a quick trip to the pharmacy or online store for inexpensive and easy to use strip sensors. Our Over the counter platform will eliminate the need for scheduled appointments at clinics and can allow you to make the best decisions for you and your family.  Giving individuals the freedom of quality diagnoses anywhere and anytime will drastically reduce suffering and the impact caused by prominent diseases on public health.

Patents
UPDATE:On Oct. 9th, 2024, Transversal Therapeutics received a notice of allowance from the USPTO for their patent titled ""Durable Enzyme-Based Biosensor and Process for Drop Deposition Immobilization", a core piece of their electrochemical platform.
0%